Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Rectum Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT06300489
What this trial is testing

Genotype-driven Weekly Irinotecan Liposomes in Combination With Capecitabine-based Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Zhejiang Cancer Hospital 30
Not applicableStudy completedNCT04271657
What this trial is testing

RadioPathomics Artificial Intelligence Model to Predict nCRT Response in Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University 100
Testing effectiveness (Phase 2)UnknownNCT03503630
What this trial is testing

Short-course Radiation Followed by mFOLFOX-6 Plus COMPOUND 2055269 for Locally-advanced Rectal Adenocarcinoma

Who this might be right for
Locally Advanced Rectal Cancer
Ali Shamseddine 44
Testing effectiveness (Phase 2)Ended earlyNCT01347645
What this trial is testing

Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer

Who this might be right for
Colon CancerRectal Cancer
Eisai Inc. 82
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07314528
What this trial is testing

Evaluating the Impact of GLP-1 Receptor Agonists With Total Neoadjuvant Therapy in Rectal Cancer

Who this might be right for
Rectal Cancer PatientsObesity &Amp; OverweightLocally Advanced Rectal Cancer (LARC)+2 more
St. James's Hospital, Ireland 42
Testing effectiveness (Phase 2)Ended earlyNCT00353457
What this trial is testing

Capecitabine,Oxaliplatin & Erbitux Given Throughout Multi-Modal Therapy for Locally Advanced Rectal Adenocarcinoma

Who this might be right for
Rectal Cancer
Abramson Cancer Center at Penn Medicine 6
Large-scale testing (Phase 3)UnknownNCT02484040
What this trial is testing

Two-week Course Versus Conventionally Fractionated Chemoradiotherapy in Rectal Cancer

Who this might be right for
Response to ToxinToxicityRecurrence
Jong Hoon Lee 370
Not applicableUnknownNCT03577808
What this trial is testing

Organoids in Predicting Chemoradiation Sensitivity on Rectal Cancer

Who this might be right for
OrganoidsRectal CancerChemoradiation
Zhen Zhang 80
Not applicableStudy completedNCT05495308
What this trial is testing

"Oncologic Results and Risk Factors for Recurrence in Patients With Locally Advanced Rectal Cancer and Pathologic Complete Response After Neoadjuvant Treatment. Results From an Observational Retrospective Multicenter Long-term Follow-up Study".

Who this might be right for
Rectal Cancer, AdenocarcinomaRectal Cancer Stage IIRectal Cancer Stage III+2 more
Hospital San Carlos, Madrid 4
Testing effectiveness (Phase 2)Looking for participantsNCT05601505
What this trial is testing

Circulating Tumor DNA-guided Neoadjuvant Treatment Strategy for Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal CarcinomaCirculating Tumor DNA
Peking Union Medical College Hospital 470
Testing effectiveness (Phase 2)Looking for participantsNCT05450029
What this trial is testing

Neoadjuvant Chemoradiotherapy Plus Sintilimab for Intermediate/High Immunoscore Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Yanhong Deng 51
Large-scale testing (Phase 3)Looking for participantsNCT03875781
What this trial is testing

Non Inferiority Study of Preoperative Chemotherapy Without Pelvic Irradiation for Rectal Cancer

Who this might be right for
Rectal CancerAdvanced Cancer
Assistance Publique - Hôpitaux de Paris 540
Very early researchEnded earlyNCT03280277
What this trial is testing

Ferumoxytol-Enhanced MRI in Imaging Lymph Nodes in Patients With Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal CarcinomaStage III Rectal Cancer AJCC v7Stage IIIA Rectal Cancer AJCC v7+2 more
OHSU Knight Cancer Institute 2
Testing effectiveness (Phase 2)Study completedNCT00972881
What this trial is testing

Capecitabine, Irinotecan Hydrochloride, Cetuximab, and Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
University College, London 82
Not applicableNot Yet RecruitingNCT07183124
What this trial is testing

3D Modeling for Detecting Locally Advanced Rectal Cancer With Positive Circumferential Resection Margin

Who this might be right for
General SurgeryOncologyMedical Informatics
Taichung Veterans General Hospital 1,500
Testing effectiveness (Phase 2)Study completedNCT03365882
What this trial is testing

S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery

Who this might be right for
Colon AdenocarcinomaERBB2 Gene AmplificationRectal Adenocarcinoma+16 more
SWOG Cancer Research Network 240
Testing effectiveness (Phase 2)Study completedNCT01333709
What this trial is testing

Multicenter Phase 2 Trial: a Tailored Strategy for Locally Advanced Rectal Carcinoma

Who this might be right for
Locally Advanced Malignant NeoplasmRectal Carcinoma
Institut du Cancer de Montpellier - Val d'Aurelle 150
Not applicableNot Yet RecruitingNCT07404228
What this trial is testing

Multidimensional Study Designed to Develop a Methodological Framework Based on MRI Data to Predict Pathological Complete Response (pCR) in Patients With Locally Advanced Rectal Cancer After Neoadjuvant Treatment

Who this might be right for
Rectal CancerChemoradiotherapyMri
Institut du Cancer de Montpellier - Val d'Aurelle 115
Not applicableStudy completedNCT06898359
What this trial is testing

Role of Gut Microbiota in Neoadjuvant Radioimmunotherapy for MSS, Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Yanhong Deng 29
Not applicableUnknownNCT04278274
What this trial is testing

Post-Neoadjuvant Treatment MRI Based AI System to Predict pCR for Rectal Cancer

Who this might be right for
Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University 205
Next Page